Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study

Veena Hoffman; Jesper Hallas; Marie Linder; Andrea V. Margulis; Brandon T. Suehs; Alejandro Arana; Cheryl Enger; Libby Horter; Ingvild Odsbu; Morten Olesen; Susana Perez-Gutthann; Yihua Xu; Nina S. Kristiansen; Kwame Appenteng; Stefan de Vogel; John D. Seeger

Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study

Veena Hoffman, Jesper Hallas, Marie Linder, Andrea V. Margulis, Brandon T. Suehs, Alejandro Arana, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susana Perez-Gutthann, Yihua Xu, Nina S. Kristiansen, Kwame Appenteng, Stefan de Vogel, John D. Seeger

Clinical Pharmacology, Pharmacy and Environmental Medicine

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Pharmacoepidemiology and Drug Safety
Volume	30
Issue number	Suppl. 1
Pages (from-to)	85
Number of pages	1
ISSN	1053-8569
Publication status	Published - 1. Aug 2021
Event	37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Duration: 23. Aug 2021 → 25. Aug 2021

Conference

Conference	37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Period	23/08/2021 → 25/08/2021

Cite this

Hoffman, V., Hallas, J., Linder, M., Margulis, A. V., Suehs, B. T., Arana, A., Enger, C., Horter, L., Odsbu, I., Olesen, M., Perez-Gutthann, S., Xu, Y., Kristiansen, N. S., Appenteng, K., de Vogel, S., & Seeger, J. D. (2021). Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study. Pharmacoepidemiology and Drug Safety, 30(Suppl. 1), 85.

@article{3708bcd16d6147349ffab3fc04f2765e,

title = "Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study",

author = "Veena Hoffman and Jesper Hallas and Marie Linder and Margulis, {Andrea V.} and Suehs, {Brandon T.} and Alejandro Arana and Cheryl Enger and Libby Horter and Ingvild Odsbu and Morten Olesen and Susana Perez-Gutthann and Yihua Xu and Kristiansen, {Nina S.} and Kwame Appenteng and {de Vogel}, Stefan and Seeger, {John D.}",

year = "2021",

month = aug,

day = "1",

language = "English",

volume = "30",

pages = "85",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "Suppl. 1",

note = "null ; Conference date: 23-08-2021 Through 25-08-2021",

}

Hoffman, V, Hallas, J, Linder, M, Margulis, AV, Suehs, BT, Arana, A, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, NS, Appenteng, K, de Vogel, S & Seeger, JD 2021, 'Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study', Pharmacoepidemiology and Drug Safety, vol. 30, no. Suppl. 1, pp. 85.

Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study. / Hoffman, Veena; Hallas, Jesper; Linder, Marie et al.

In: Pharmacoepidemiology and Drug Safety, Vol. 30, No. Suppl. 1, 01.08.2021, p. 85.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study

AU - Hoffman, Veena

AU - Hallas, Jesper

AU - Linder, Marie

AU - Margulis, Andrea V.

AU - Suehs, Brandon T.

AU - Arana, Alejandro

AU - Enger, Cheryl

AU - Horter, Libby

AU - Odsbu, Ingvild

AU - Olesen, Morten

AU - Perez-Gutthann, Susana

AU - Xu, Yihua

AU - Kristiansen, Nina S.

AU - Appenteng, Kwame

AU - de Vogel, Stefan

AU - Seeger, John D.

PY - 2021/8/1

Y1 - 2021/8/1

M3 - Conference abstract in journal

VL - 30

SP - 85

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - Suppl. 1

Y2 - 23 August 2021 through 25 August 2021

ER -